See you in 2023
September 21 & 22
Woodstock VT
Email: 3Dsymposium@hitchcock.org
Dartmouth College Green by Peter Rintels
ABOUT
For 20 years the 3D Dartmouth Device Symposium has been bringing together a distinguished group of thought leaders representing the clinical, business, governmental, financial and legal segments of the medical device community.
The Symposium provides an important forum to exchange ideas and discuss problems common to us all as we strive to bring new technologies to improve patient care.
PROGRAM
3D 2022
October 20 & 21, 2022
Woodstock VT
Session I
Real World Evidence
Aggregating large representative data sets-Leveraging AI
Moderator
Michael Jaff, DO / Boston Scientific
Round Table Conversation
Ryan Ahern, MD / Truveta
David Cohen, MD / CRF
Harlan Krumholz, MD / Yale/Hugo
Steve Farmer, MD, PhD / CMS
Truveta: Paradigm Shift-Impact on Post Market Assessment
Ryan Ahern, MD, Chief Medical Officer / Truveta
Meet Hugo
Harlan Krumholz, MD / Hugo Health & Yale University
Session II
Real World Evidence: Established Mandated Registries (NCDR, TVT)
Why is it so difficult to embed RCTs?
Moderator
Michael Mack / Baylor Scott & White Health
SAFE-PCI Women
Mitch Krucoff, DCRI-Duke
TAVR-RV/LV (PRAGMATIC-PACE)
Michael Mack / Baylor Scott & White Health
Round Table Conversation
Ori Ben-Yehuda, MD / CRF
Nicole Ibrahim / FDA-CDRH
Martin Leon, MD / Columbia/CRF
Sreek Vemulapalli, MD / NCDR & Duke University
Larry Wood / Edwards Life Sciences
Session III
TCET (Previously known as MCIT)
Where do we go from here?
What does it mean for devices with the Breakthrough designation?
Moderator
Emily Zeitler, MD, MPH / Heart & Vascular Center, Dartmouth Health
Framing Comments
Steven Farmer, MD, PhD
Chief Strategy Officer for Coverage
Centers for Medicare and Medicaid Services
Round Table Conversation
Andrew Farb / FDA-CDRH
Keith Dawkins, MD / Shockwave Medical
Tamara Syrek-Jensen, JD / CMS
Sean Tunis, MD / Tufts Medical Center
Session IV
On the Cusps: Tricuspid Valve Devices
CED/NCD Is it appropriate/How should it be constructed?
Moderator & Framing Comments
Martin B. Leon, MD / Columbia University / CRF
Round Table Conversation
James Fann, MD / Half Moon Medical/Stanford
Steven Farmer, MD, PhD / CMS
Ted Feldman, MD / Edwards Lifesciences
Neal Moat, MS, FRCS / Abbott
Mauro Moscucci, MD / FDA-CDRH
Michael Young, MD / Dartmouth Health/Heart &
Vascular Center
CEO Round Table Conversation: Emerging from COVID - Has the Dust Really Settled-Have we reached a new Equilibrium
Moderator
Paul LaViolette
Managing Partner, SV Health Investors
Andrew Cleeland / Fogarty Innovation
Doron Harlev / Affera/Medtronic
Mike Mussallem / Edwards Life Sciences
Session V
Medical Device-Smart App Driven Management:
Navigating new Landscapes
Leveraging AI & Machine Learning, addressing cybersecurity concerns.
A Fictitious Case Study
Moderator
Robert Kazmierski, PhD
FDA-CDRH
Framing the Problem
Adam Jacobs / Sunrise Labs
VaporWare Medical (A Fictitious Case)
Aaron V. Kaplan
Heart & Vascular Center/Dartmouth Health
Case Study Participants
Lauren Baker, PhD / Insight Medical Consulting
Adam Jacobs / Sunrise Labs
Brendan O'Leary / FDA-CDRH
Jessica Paulsen / FDA-CDRH
Sam Surette / Apple
Session VI
Moving Primary Care from the Clinic to the Pharmacy/Retail Store
Impact on the Medical Device Ecosystem
Moderator
Lauren Gilstrap, MD
Heart & Vascular Center/Dartmouth Health
A Vison for the Future
Srinath Adusumalli, MD
CVSHealth
Round Table Conversation
Don Cutlip, MD / Beth Israel-Deaconess/Harvard
Jodi Akin / Hawthorne Effect
Ami Bhatt / American College of Cardiology
Ian Meredith, MD, PhD / Boston Scientific
Brendan O'Leary / FDA-CDRH
The Theranos Story
A Cautionary Tale for the Start-up Ecosystem
John Carreyrou
Author / Journalist
with
Syd Finkelstein, PhD
Roth Professor of Management
Tuck School of Business at Dartmouth
PANEL MEMBERS
Alphabetical - Last Name
Attendees
Alphabetical - Last Name
TEAM
HISTORY
History 2003-2009
History 2010-2016
History 2017-2021